Form 8-K - Current report:
SEC Accession No. 0000950170-24-013050
Filing Date
2024-02-09
Accepted
2024-02-09 07:10:49
Documents
19
Period of Report
2024-02-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgc-20240209.htm   iXBRL 8-K 45694
2 EX-99.1 cgc-ex99_1.htm EX-99.1 621182
3 GRAPHIC img62664582_0.jpg GRAPHIC 47018
4 GRAPHIC img62664582_1.jpg GRAPHIC 13543
5 GRAPHIC img62664582_2.jpg GRAPHIC 13543
6 GRAPHIC img62664582_3.jpg GRAPHIC 47018
7 GRAPHIC img62664582_4.jpg GRAPHIC 13543
8 GRAPHIC img62664582_5.jpg GRAPHIC 13543
  Complete submission text file 0000950170-24-013050.txt   1032030

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgc-20240209.xsd EX-101.SCH 30850
20 EXTRACTED XBRL INSTANCE DOCUMENT cgc-20240209_htm.xml XML 4505
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 24611149
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)